ZNF549 Inhibitors
Chemical inhibitors of ZNF549 include a variety of compounds that target different kinases and signaling pathways to achieve functional inhibition. Staurosporine, a well-known kinase inhibitor, can inhibit ZNF549 by preventing the phosphorylation processes essential for its activation, thus leading to a functional inhibition of the protein. LY294002 and Wortmannin, both inhibitors of PI3K, can decrease the phosphorylation of proteins downstream of PI3K, including ZNF549, thereby diminishing its activity. Similarly, PD98059 and U0126 target the MEK enzymes in the MAPK/ERK pathway, a pathway that can be crucial for the phosphorylation of ZNF549. By inhibiting MEK, these compounds prevent the activation of ERK and thus the phosphorylation and potential activation of ZNF549.
Further, PP2 focuses on Src family tyrosine kinases, which, when inhibited, can lead to reduced phosphorylation and activity of ZNF549 if it is part of the Src signaling pathway. SB203580, which impedes p38 MAP kinase, and SP600125, which targets JNK, both can inhibit ZNF549 by blocking the respective MAPK pathways that might be involved in its phosphorylation and subsequent activity. Rapamycin inhibits mTOR and can suppress downstream signaling that could be necessary for ZNF549 function. Dasatinib, with its broad spectrum of kinase inhibition, can disrupt various kinases that would phosphorylate ZNF549 or its regulatory proteins. PD168393, an irreversible inhibitor of EGFR tyrosine kinase, can inhibit ZNF549 by preventing the activation of downstream pathways that could be involved in ZNF549's functional state. Lastly, Triciribine specifically inhibits AKT, which can lead to the inhibition of ZNF549 by preventing the necessary AKT-mediated phosphorylation events that might be essential for ZNF549's function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. It can inhibit ZNF549 by inhibiting the kinases that are required for its phosphorylation and activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K, a kinase upstream of many signaling pathways. By inhibiting PI3K, LY294002 can reduce the phosphorylation of proteins downstream, which may include ZNF549 or its essential modulators. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of MEK, which is part of the MAPK/ERK pathway. By inhibiting MEK, PD98059 can prevent the activation of ERK and subsequent phosphorylation of ZNF549. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a selective inhibitor of Src family tyrosine kinases. By inhibiting these kinases, PP2 can prevent the phosphorylation of ZNF549 if it relies on Src-mediated signaling for its function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, preventing the activation of the MAPK/ERK pathway. ZNF549 inhibition can occur if its activity is dependent on the phosphorylation events mediated by this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K. It can inhibit ZNF549 by blocking the PI3K/AKT signaling pathway, which may be necessary for the phosphorylation and activation of ZNF549. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAP kinase. It can inhibit ZNF549 by preventing activation of the p38 MAPK pathway, potentially impacting the phosphorylation state of ZNF549. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. By inhibiting mTOR, Rapamycin can suppress the downstream signaling required for the phosphorylation and functionality of ZNF549. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor. It can inhibit ZNF549 by inhibiting various kinases that may phosphorylate ZNF549 directly or phosphorylate proteins that regulate ZNF549 activity. | ||||||
Imatinib mesylate | 220127-57-1 | sc-202180 sc-202180A | 25 mg 100 mg | $45.00 $111.00 | 61 | |
PD168393 is an irreversible inhibitor of EGFR tyrosine kinase. It can prevent the activation of downstream signaling pathways that may be involved in the phosphorylation and activation of ZNF549. | ||||||